These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25185371)

  • 1. Post-marketing safety monitoring of shenqifuzheng injection: a solution made of dangshen (Radix Codonopsis) and huangqi (Radix Astragali Mongolici).
    Ai Q; Zhang W; Xie Y; Huang W; Liang H; Cao H
    J Tradit Chin Med; 2014 Aug; 34(4):498-503. PubMed ID: 25185371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ["Re-evaluation upon suspected event" is an approach for post-marketing clinical study: lessons from adverse drug events related to Bupleuri Radix preparations].
    Wu SX; Sun HF; Yang XH; Long HZ; Ye ZG; Ji SL; Zhang L
    Zhongguo Zhong Yao Za Zhi; 2014 Aug; 39(15):2983-8. PubMed ID: 25423845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmarketing studies on safety of Dengfeng shenmai injection.
    Wang L; Zhang W; Xie Y; Bai Y; Wang M; Ai Q
    J Tradit Chin Med; 2013 Dec; 33(6):827-31. PubMed ID: 24660618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmarketing safety evaluation: depside salt injection made from Danshen (Radix Salviae Miltiorrhizae).
    Chang Y; Zhang W; Xie Y; Xu X; Sun R; Wang Z; Yan R
    J Tradit Chin Med; 2014 Dec; 34(6):749-53. PubMed ID: 25618981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Post-marketing surveillance of
    Li XX; Zhuo L; Yang YH; Zhan SY; Zhai SD
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Feb; 38(2):248-252. PubMed ID: 28231676
    [No Abstract]   [Full Text] [Related]  

  • 6. Post-marketing safety surveillance and re-evaluation of Xueshuantong injection.
    Li C; Xu T; Zhou P; Zhang J; Guan G; Zhang H; Ling X; Li W; Meng F; Liu G; Lv L; Yuan J; Li X; Zhu M
    BMC Complement Altern Med; 2018 Oct; 18(1):277. PubMed ID: 30326892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of post marketing safety reevaluation of shenqi fuzheng injection].
    Ai QH; Li YY; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3633-6. PubMed ID: 25532410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmarketing evaluation on the safety and effectiveness of deng-zhanxixin injection made from Dengzhanxixin (Herba Erigerontis Breviscapi).
    Li Y; Lin G; Xie Y; Zhang W; Guo T
    J Tradit Chin Med; 2015 Feb; 35(1):99-103. PubMed ID: 25842735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Technical specifications for intensive hospital safety monitoring of post-marketing Chinese medicine (draft version for comments)].
    Xie YM; Liao X; Zhao YB; Li MQ; Zhang YL; Ma R; Xian SX; Liu J; Li SY; Wen ZH; Yang ZQ; Zou JD; Sun HS; He Y; Li XL; Jiang JJ; Wang ZF; Li YY; Wang LX; Chang YP; Yang W; Zhang W
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2919-24. PubMed ID: 24471304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of the Xuesaitong injection in China: results from a large-scale multicentre post-marketing surveillance study in a real-world setting.
    He Y; Gao XM; Li L; Liu XG; Liu W; Hong XJ; Huang BH; Yang HL; Xue MH; Wu XJ; Liu JF
    Curr Med Res Opin; 2020 Dec; 36(12):1947-1953. PubMed ID: 33016133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of clinical use of post-marketing hospital centralized monitoring of Xiyanping injection].
    Zhao Y; Shi C; Huang P
    Zhongguo Zhong Yao Za Zhi; 2016 Feb; 41(4):743-747. PubMed ID: 28871704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Post-marketing safety surveillance of Diemailing Kudiezi injection: real world study in 30 233 cases].
    Liao X; Yu DD; Xie YM; Zhang YL; He Y; Zhang Y; Liu Y; Yi DH; Wang YY
    Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(15):2857-2863. PubMed ID: 29139248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of safety evidence for Xingxue Shuxuening injection.
    Yang W; Zhang W; Xie Y; Han B
    J Tradit Chin Med; 2014 Oct; 34(5):604-8. PubMed ID: 25417413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Establishment of model of traditional Chinese medicine injections post-marketing safety monitoring].
    Guo XE; Zhao YB; Xie YM; Zhao LC; Li YF; Hao Z
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2974-8. PubMed ID: 24471314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enlightenment of adverse reaction monitoring on safety evaluation of traditional Chinese medicines].
    Song HB; Du XX; Ren JT; Yang L; Guo XX; Pang Y
    Zhongguo Zhong Yao Za Zhi; 2015 Apr; 40(8):1620-3. PubMed ID: 26281610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immuno-enhancement effects of Shenqi Fuzheng Injection on cyclophosphamide-induced immunosuppression in Balb/c mice.
    Wang J; Tong X; Li P; Cao H; Su W
    J Ethnopharmacol; 2012 Feb; 139(3):788-95. PubMed ID: 22212503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical analysis of Radix Astragali (Huangqi) in China: a comparison with its adulterants and seasonal variations.
    Ma XQ; Shi Q; Duan JA; Dong TT; Tsim KW
    J Agric Food Chem; 2002 Aug; 50(17):4861-6. PubMed ID: 12166972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on 10 409 cases of post-marketing safety Danhong injection centralized monitoring of hospital].
    Li X; Tang J; Meng F; Li C; Xie Y
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2783-5. PubMed ID: 22292364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of optimal combination of Huangqi (Radix Astragali Mongolici) and Ezhu (Rhizoma Curcumae Phaeocaulis) on proliferation and apoptosis of A549 lung cancer cells.
    Xu C; Wang Y; Feng J; Qin L; Xu R; Dou Y
    J Tradit Chin Med; 2018 Jun; 38(3):351-358. PubMed ID: 32185966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of Volatile Components and Special Aroma in Fresh Roots of Codonopsis Radix].
    Zhong Yao Cai; 2016 Sep; 39(9):2005-12. PubMed ID: 30207655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.